+ All Categories

Home > Documents > House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to...

House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to...

Date post:	06-Sep-2021
Category:	Documents
Upload:	others
View:	8 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

23

Transcript

Page 1: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 2: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 3: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 4: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 5: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 6: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 7: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 8: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 9: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 10: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 11: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 12: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 13: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 14: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 15: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 16: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 17: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 18: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 19: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 20: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 21: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 22: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Page 23: House Committee on Oversight and Reform · 2021. 4. 29. · NDA filing in US Converted to exclusivity INDA filing in Europe NDA approval in U.S INDA approval in Europe Oxymorphone

Recommended

205777Orig1s000 - Food and Drug Administration · The ONDQA Biopharmaceutics team has reviewed NDA 205-777 for filing purposes. We found this NDA fileablefrom a Biopharmaceutics perspective.

InDA Brochure India

INDA presentation

NDA Regulatory Filing Review€¦ · NDA Regulatory Filing Review Page7 Appendix A to NDARegulatory Filing Review NOTE: The term "original application" or"originalNDA" as usedin this

NDA (France) Fall 2012 NDA Automne 2012 - RF Studiorfstudio.fr/wp-content/uploads/2016/09/NDA-2012-Tai-Ping-Paris.pdf · NDA (France) Fall 2012 NDA Automne 2012

Metro project in inda

Inda Presentation Roche Final April 2012

House Committee on Oversight and Reform2021. 4. 29. · INDA filing- Australia NDA approval- Australia Hydrocodone NDA filing- USA approval- USA Amount 500 1 ,ooo 1 ,ooo 4,000 Payment

Golden triangle inda travel

Inda by Maria Christina

1 Bacterial Meningitis SINGHI Inda

INDA.2.(Chart_good)Discover Your IQ Potential

state of urban service delivery in inda

Government & Nonprofit

Investigational New drug application [INDA]

Health & Medicine

INDA Admission Interviewcuinda.com/media/2015/02/INDA-Interview-2015.pdf · 2015. 2. 24. · INDA Admission Interview ... If you prefer not to wear your school uniform, please feel

rice Inda - indiarestaurantsudbury.co.uk

CENTER FOR DRUG EVALUATION AND RESEARCH...CLINICAL FILING CHECKLIST FOR NDA/BLA or Supplement File name: 5_Clinical Filing Checklist for NDA_BLA or Supplement 010908 1 NDA/BLA Number: